The markets opened lower with the Dow slipping 16 points to 24,341 as President Donald Trump weighs withdrawing from the Iran nuclear deal. Nasdaq lost 10 points to 7255.
On the upside
Valeant Pharmaceuticals (NYSE: VRX) reported greater than expected revenue for the first quarter and announced that it will change its name to Bausch Health Companies.
Expeditors International of Washington (Nasdaq: EXPD) reported higher first quarter earnings and revenue.
Discovery (Nasdaq: DISCA) reported higher first quarter revenue.
On the downside
Nevro (NYSE: NVRO) widened losses for the first quarter.
Amicus Therapeutics (Nasdaq: FOLD) reported a loss for the first quarter.
Camping World Holdings (NYSE: CWH) disappointed with sharply lower first quarter earnings.
In the broad market, declining issues outpaced advancers by a margin of 6 to 5 on the NYSE while advancers edged out decliners by a slim margin on Nasdaq. The broader S&P 500 slipped 2 points to 2,670. Bitcoin plummeted $279 to $9,115.